1971
DOI: 10.1016/0022-510x(71)90211-5
|View full text |Cite
|
Sign up to set email alerts
|

Effects of 5-HTP on sleep in mongol children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0
1

Year Published

1973
1973
2012
2012

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 5 publications
0
4
0
1
Order By: Relevance
“…3032,57 Petre-Quadens and de Greef 57 and Petre-Quadens and de Lee 30 reported on the effects of 5-hydroxytryptophan (5-HTP) on “quiet” (non-REM) and “paradoxical” (REM) sleep in children with DS. Based on earlier findings by Bazelon et al 58 who observed improvements in hypotonia, 5-HTP was administered to children with DS in a quasi-experimental study.…”
Section: Resultsmentioning
confidence: 99%
“…3032,57 Petre-Quadens and de Greef 57 and Petre-Quadens and de Lee 30 reported on the effects of 5-hydroxytryptophan (5-HTP) on “quiet” (non-REM) and “paradoxical” (REM) sleep in children with DS. Based on earlier findings by Bazelon et al 58 who observed improvements in hypotonia, 5-HTP was administered to children with DS in a quasi-experimental study.…”
Section: Resultsmentioning
confidence: 99%
“…These histograms demonstrated that retardates v/ere particularly deficient in intervals under 1 sec; that is, they were deficient in eye movements occurring quickly in succession (within 1 sec of one another). In a second study (9), this finding was replicated in mongoloid infants; moreover, administration of 5-hydroxy tryptophan increased the number of intervals under 1 sec.…”
mentioning
confidence: 52%
“…Importance of 5-HT in DS is also a much discussed subject [21][22][23][24]. However, genetic polymorphisms in these neurotransmitters, in association with DS, have never been explored.…”
Section: Discussionmentioning
confidence: 98%
“…Reduced level of 5HT is a clinical characteristic of DS patients [21] and investigations on blood platelets isolated from DS patients and transgenic mice (harbouring human CuZnSOD gene) revealed reduced 5-HT uptake associated with overexpression of Cu-Zn superoxide dismutase gene [22]. Muscular tone, motor activity [23] and sleep abnormalities [24] observed in DS patients were reported to improve after administration of 5HT precursor, 5-hydroxytryptophan (5-HTP). However, treatment with 5-HTP was discontinued due to serious side effects.…”
Section: Introductionmentioning
confidence: 96%